The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 12, 2022
Filed:
Dec. 13, 2016
Applicant:
Nestec S.a., Vevey, CH;
Inventors:
Nora Schneider, Epalinges, CH;
Jonas Hauser, Lausanne, CH;
Sean Deoni, Providence, RI (US);
Tamas Bartfai, Stockholm, SE;
Jonathan O'Regan, County Kerry, IE;
Assignee:
Societe des Produits Nestle S.A., Vevey, CH;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A23L 33/00 (2016.01); A23L 33/12 (2016.01); A23L 33/15 (2016.01); A23L 33/16 (2016.01); A61K 45/06 (2006.01); A24B 15/38 (2006.01); A61P 25/28 (2006.01); A61K 9/00 (2006.01); A61K 31/14 (2006.01); A61K 31/202 (2006.01); A61K 31/519 (2006.01); A61K 31/661 (2006.01); A61K 31/70 (2006.01); A61K 31/714 (2006.01); A61K 33/00 (2006.01); A61K 33/06 (2006.01); A61K 33/26 (2006.01); A61K 33/30 (2006.01); A61K 33/42 (2006.01);
U.S. Cl.
CPC ...
A23L 33/40 (2016.08); A23L 33/12 (2016.08); A23L 33/15 (2016.08); A23L 33/16 (2016.08); A23L 33/30 (2016.08); A24B 15/38 (2013.01); A61K 9/0095 (2013.01); A61K 31/14 (2013.01); A61K 31/202 (2013.01); A61K 31/519 (2013.01); A61K 31/661 (2013.01); A61K 31/70 (2013.01); A61K 31/714 (2013.01); A61K 33/00 (2013.01); A61K 33/06 (2013.01); A61K 33/26 (2013.01); A61K 33/30 (2013.01); A61K 33/42 (2013.01); A61K 45/06 (2013.01); A61P 25/28 (2018.01); A23V 2002/00 (2013.01);
Abstract
A synthetic nutritional composition comprising a phospholipid and/or a metabolic precursor and/or metabolite thereof for use to promote, support or optimise de novo myelination, in particular the de novo myelination trajectory, and/or brain structure, and/or brain connectivity, and/or intellectual potential and/or cognitive potential, and/or learning potential and/or cognitive functioning in a subject, in particular a formula fed subject.